National Coverage Analysis (NCA) View Public Comments

Positron Emission Tomography (FDG) for Cervical Cancer

Public Comments

Commenter Comment Information
Rathbun, Jill Title: Director of Government Relations
Organization: Society of Gynecologic Oncologists
Date: 09/11/2009
Comment:

September 11, 2009

Tamara Syrek Jensen, J.D.
Acting Director, Coverage and Analysis Group
Centers for Medicare & Medicaid Services
7500 Security Blvd., Mail Stop C1-09-06
Baltimore, MD 21244

Re: Comments on Proposed Decision Memorandum for Positron Emission Tomography (FDG-PET) for Cervical Cancer (CAG-00181R2)

Dear Acting Director Jensen:

The Society of Gynecologic Oncologists (SGO) thanks the Centers for Medicare and Medicaid Services (CMS) for

More

Schuman, Ilyse Title: Vice President, NEMA
Organization: Managing Director, Medical Imaging & Technology Alliance
Date: 09/11/2009
Comment:

September 11, 2009

Tamara Syrek Jensen
Acting Director, Coverage and Analysis Group
Centers for Medicare and Medicaid Services
Department of Health and Human Services
Mailstop: C1-09-06
7500 Security Blvd.
Baltimore, MD 21244

Re: Proposed Decision Memorandum for Positron Emission Tomography (FDG) for Cervical Cancer (CAG-00181R2)

Dear Ms. Jensen:

The Medical Imaging and Technology Alliance (MITA), a division

More

Bocchino, Carmella Title: EVP, Clinical Affairs and Strategic Planning
Organization: America's Health Insurance Plans (AHIP)
Date: 09/10/2009
Comment:

September 12, 2009

Tamara Syrek Jensen, JD
Acting Director, Coverage and Analysis Group
Centers for Medicare and Medicaid Services
Mail Stop C1-09-06
7500 Security Boulevard
Baltimore, Maryland 21244-1850

Dear Ms. Syrek Jensen,

Thank you for the opportunity to comment on the Centers for Medicare and Medicaid Services' (CMS's) national coverage decision (NCD), Positron Emission Tomography (FDG) for Cervical Cancer (CAG-00181R2).

More

Lamkin, RN, MPH, Luana R. Title: President
Organization: Association of Community Cancer Centers
Date: 09/10/2009
Comment:

September 11, 2009

BY ELECTRONIC DELIVERY

Tamara Syrek Jensen, JD
Acting Director, Coverage and Analysis Group
Centers for Medicare and Medicaid Services
7500 Security Boulevard
Mail Stop C1-09-06
Baltimore, Maryland 21244

Re: Proposed Coverage Decision Memorandum for FDG Positron Emission Tomography to Guide Initial Management of Cervical Cancer (CAG-00181R2)

Dear Ms. Jensen:

The Association of

More

Carol, M.D., Mark Title: Chief Medical Officer
Organization: Alliance HealthCare Services
Date: 09/09/2009
Comment:

On behalf of Alliance HealthCare Services and its Alliance Imaging division, the largest provider of PET and PET/CT services in the nation, we appreciate the opportunity to comment on CMS’s proposed decision memorandum regarding the expansion of PET and PET/CT coverage to include staging of cervical cancer. We strongly support and agree with the proposed determination to expand coverage for the use of PET and PET/CT imaging for cervical cancer staging thereby allowing treating

More

Divgi, Chaitanya Title: Chief, Nuclear Medicine & Clin Molecular Imaging
Organization: University of Pennsylvania
Date: 08/31/2009
Comment:

The decision to cover FDG PET/CT for cervical cancer staging is timely and appropriate, and will result in improved delivery of care for our patients.

McCarthy, Timothy Title: President
Organization: Academy of Molecular Imaging
Date: 08/27/2009
Comment:

We are writing in strong support of the Centers for Medicare & Medicaid Services’ (CMS) Proposed Decision Memorandum for Positron Emission Tomography (FDG) for Cervical Cancer, CAG- 00181R2, which proposes to cover FDG PET (PET) for staging in beneficiaries who have biopsy- proven cervical cancer, and to remove the current Coverage with Evidence Development (CED) limitations on the use of PET for the initial staging of cervical cancer.

This letter is submitted jointly on

More